Financials Femasys Inc.

Equities

FEMY

US31447E1055

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
1.27 USD -8.63% Intraday chart for Femasys Inc. +2.83% +30.26%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 46.02 10.63 21.11 28.07 - -
Enterprise Value (EV) 1 46.02 10.63 21.11 28.07 28.07 28.07
P/E ratio -3.48 x -0.94 x -1.05 x -1.84 x -3.63 x -4.7 x
Yield - - - - - -
Capitalization / Revenue 39 x 8.81 x 19.7 x 5.6 x 1.68 x 0.94 x
EV / Revenue 39 x 8.81 x 19.7 x 5.6 x 1.68 x 0.94 x
EV / EBITDA - - - - - -
EV / FCF -5.59 x - - -1.34 x -2 x -2 x
FCF Yield -17.9% - - -74.8% -49.9% -49.9%
Price to Book - - - - - -
Nbr of stocks (in thousands) 11,800 11,814 21,650 22,099 - -
Reference price 2 3.900 0.9000 0.9750 1.270 1.270 1.270
Announcement Date 3/24/22 3/30/23 3/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 1.18 1.206 1.072 5.015 16.69 29.88
EBITDA - - - - - - -
EBIT 1 - -8.337 -11.6 -14.51 -15.91 -15.33 -15.84
Operating Margin - -706.69% -961.7% -1,353.44% -317.24% -91.87% -53.02%
Earnings before Tax (EBT) 1 - - -11.39 -14.24 -15.88 -15.08 -15.49
Net income 1 -6.915 - -11.39 -14.25 -15.88 -15.08 -15.49
Net margin - - -944.62% -1,329.06% -316.57% -90.37% -51.84%
EPS 2 -0.8000 -1.120 -0.9600 -0.9300 -0.6900 -0.3500 -0.2700
Free Cash Flow 1 - -8.238 - - -21 -14 -14
FCF margin - -698.29% - - -418.72% -83.9% -46.85%
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 2/12/21 3/24/22 3/30/23 3/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 - 0.2543 0.3214 0.3031 0.3475 0.2342 0.294 0.3205 0.2444 0.2131 0.2711 1.137 1.307 1.542 3.95
EBITDA - - - - - - - - - - - - - - -
EBIT 1 - -2.358 -2.883 -2.66 -3.057 -3 - -2.936 -4.081 -4.45 -3.463 -5.2 -5.4 -5.6 -
Operating Margin - -927.04% -896.91% -877.56% -879.87% -1,280.89% - -916.03% -1,670.18% -2,087.9% -1,277.07% -457.34% -413.26% -363.24% -
Earnings before Tax (EBT) 1 - - - -2.634 -2.983 -2.888 - -2.894 -3.997 -4.406 -3.6 -5.1 -5.4 -5.7 -
Net income 1 -2.26 - - -2.634 -2.983 -2.894 - -2.894 -3.997 -4.41 -3.6 -5.1 -5.4 -5.7 -
Net margin - - - -869.02% -858.47% -1,235.57% - -902.78% -1,635.66% -2,069.57% -1,327.55% -448.55% -413.26% -369.73% -
EPS 2 -0.1900 - - -0.2200 -0.2500 -0.2400 -0.2500 -0.2200 -0.2600 -0.1900 -0.1700 -0.2200 -0.2150 -0.2300 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/10/21 3/24/22 5/11/22 8/10/22 11/10/22 3/30/23 5/11/23 8/10/23 11/14/23 3/28/24 5/9/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -8.24 - - -21 -14 -14
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - 0.31 - - - - -
Capex / Sales - 26.01% - - - - -
Announcement Date 2/12/21 3/24/22 3/30/23 3/28/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.27 USD
Average target price
9.75 USD
Spread / Average Target
+667.72%
Consensus
  1. Stock Market
  2. Equities
  3. FEMY Stock
  4. Financials Femasys Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW